Latest Insider Transactions at Med Tech Acquisition Corp (MTACW)
This section provides a real-time view of insider transactions for Med Tech Acquisition Corp (MTACW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MedTech Acquisition Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MedTech Acquisition Corp's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 12
2024
|
Jennifer Stevens Chief Regulatory Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,752
+31.03%
|
-
|
Feb 12
2024
|
Jodi Devlin Chief of Clinical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+50.0%
|
-
|
Feb 12
2024
|
Sean Murphy Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,144
+40.2%
|
-
|
Feb 12
2024
|
Steven C Katz CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
34,144
+33.24%
|
-
|
Aug 10
2023
|
David J Matlin |
BUY
Other acquisition or disposition
|
Direct |
931,904
+50.0%
|
-
|
Jun 26
2023
|
Med Tech Acquisition Sponsor LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
6,249,999
+50.0%
|
-
|
Jun 12
2023
|
Magnetar Financial LLC |
SELL
Other acquisition or disposition
|
Indirect |
445,828
-77.04%
|
$4,458,280
$10.49 P/Share
|